Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | CNR1 | P21554 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12793392 | 0.96 | POLB (0.73) | POLBCNR1KMT2AMEN1 | |
| SCHEMBL22291866 | 0.91 | POLB (0.81) | POLBHPGDCNR1 | |
| SCHEMBL28742538 | 0.88 | POLB (0.86) | POLBCNR1KMT2AMEN1 | |
| SCHEMBL275229 | 0.83 | POLB (0.80) | POLBKMT2AMEN1 | |
| SCHEMBL11367962 | 0.81 | HPGD (0.82) | POLBHPGDKMT2AMEN1 | |
| SCHEMBL6650418 | 0.80 | CNR1 (0.77) | POLBCNR1KMT2AMEN1 | |
| SCHEMBL7338221 | 0.80 | POLB (0.79) | POLBCNR1KMT2AMEN1 | |
| SCHEMBL10893730 | 0.78 | POLB (0.71) | POLBCNR1 | |
| SCHEMBL17230525 | 0.78 | POLB (0.75) | POLBKMT2AMEN1 | |
| SCHEMBL20325057 | 0.77 | POLB (0.74) | POLBHPGDKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065196-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2011-03-17 | — | — | US | disclosed |
| US-20110065196-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065196-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | PTMS, PTMA, TST | POLB 2390/4885HPGD 3766/4885CNR1 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.